Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Cancer
|
April 8, 1999
Factors affecting the risk of contralateral Wilms tumor development: a report from the National Wilms Tumor Study Group
M J Coppes, M Arnold, J B Beckwith, et al.
Genes, Chromosomes & Cancer
|
August 5, 2000
Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor
M Y Arcellana-Panlilio, R M Egeler, E Ujack, et al.
Pediatric Research
|
August 6, 2000
Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis (FHLH)
G E Graham, L M Graham, P J Bridge, et al.
Medical and Pediatric Oncology
|
January 1, 1991
Childhood malignant lymphoma of bone
M J Coppes, C Patte, D Couanet, et al.
The American Journal of Pediatric Hematology/Oncology
|
August 1, 1992
Oxygen therapy in sickle cell disease
A Zipursky, I C Robieux, E J Brown, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
December 1, 1992
Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes
H Yeger, C Cullinane, A Flenniken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1989
Bilateral Wilms' tumor: long-term survival and some epidemiological features
M J Coppes, J de Kraker, P J van Dijken, et al.
Medical and Pediatric Oncology
|
October 23, 1997
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group
M L Brecher, M R Schwenn, M J Coppes, et al.
Pediatric Hematology and Oncology
|
October 1, 1992
Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation
I C Robieux, J D Kellner, M J Coppes, et al.
Journal of Pediatric Hematology/Oncology
|
August 13, 1999
Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy
M J Coppes, R Yanofsky, S Pritchard, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Cancer
|
April 8, 1999
Factors affecting the risk of contralateral Wilms tumor development: a report from the National Wilms Tumor Study Group
M J Coppes, M Arnold, J B Beckwith, et al.
Genes, Chromosomes & Cancer
|
August 5, 2000
Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor
M Y Arcellana-Panlilio, R M Egeler, E Ujack, et al.
Pediatric Research
|
August 6, 2000
Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis (FHLH)
G E Graham, L M Graham, P J Bridge, et al.
Medical and Pediatric Oncology
|
January 1, 1991
Childhood malignant lymphoma of bone
M J Coppes, C Patte, D Couanet, et al.
The American Journal of Pediatric Hematology/Oncology
|
August 1, 1992
Oxygen therapy in sickle cell disease
A Zipursky, I C Robieux, E J Brown, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
December 1, 1992
Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes
H Yeger, C Cullinane, A Flenniken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1989
Bilateral Wilms' tumor: long-term survival and some epidemiological features
M J Coppes, J de Kraker, P J van Dijken, et al.
Medical and Pediatric Oncology
|
October 23, 1997
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group
M L Brecher, M R Schwenn, M J Coppes, et al.
Pediatric Hematology and Oncology
|
October 1, 1992
Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation
I C Robieux, J D Kellner, M J Coppes, et al.
Journal of Pediatric Hematology/Oncology
|
August 13, 1999
Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy
M J Coppes, R Yanofsky, S Pritchard, et al.
Page
of 9